Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study

Abstract Background Several studies have shown that heart rate control with selective beta-1 blockers in septic shock is safe. In these trials, esmolol was administered 24 h after onset of septic shock in patients who remained tachycardic. While an earlier use of beta-blockers might be beneficial, s...

Full description

Bibliographic Details
Main Authors: Bruno Levy, Caroline Fritz, Caroline Piona, Kevin Duarte, Andrea Morelli, Philippe Guerci, Antoine Kimmoun, Nicolas Girerd
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Critical Care
Subjects:
Online Access:https://doi.org/10.1186/s13054-020-03445-w